Jon Todd Derbin

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.

HeartSine Technologies LLC designs and develops automatic external cardiovascular defibrillator devices. Its products include samaritan PAD 450P with CPR rate advisor, samaritan PAD 350P with CPR coaching, samaritan PAD trainer family, Pad-Pak, heart trac, samaritan CPR, and accessories. The company was founded by Andrew O'hara, Drew Hofmann and John Anderson in 1998 and is headquartered in Newtown, PA.

Part of Ventas, Inc., SynCare, Inc. provides physical, occupational, and speech therapy. The company is based in Newport Beach, CA. SynCare was acquired by VTR Assisted Living, Inc., part of Ventas, Inc. from April 23, 2003 on October 10, 1996 for $1.23 million.

Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom.